DUK
60
-4
COF
69
4
NOV
53
-2
MPC
44
5
TAP
64
3
BXP
28
-13
SRE
56
2
TDC
23
2
VMC
48
10
DVN
28
3
FITB
66
7
CHD
50
-6
NOC
35
-2
INTC
47
4
GRMN
50
2
F
48
6
BIIB
40
-2
JCI
57
2
L
39
-2
PCAR
43
3
DUK
60
-4
COF
69
4
NOV
53
-2
MPC
44
5
TAP
64
3
BXP
28
-13
SRE
56
2
TDC
23
2
VMC
48
10
DVN
28
3
FITB
66
7
CHD
50
-6
NOC
35
-2
INTC
47
4
GRMN
50
2
F
48
6
BIIB
40
-2
JCI
57
2
L
39
-2
PCAR
43
3
Financhill
Back

Novavax Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
23

NVAX
Novavax

Last Price:
$8.19
Seasonality Move:
10.91%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$107.93
Seasonality Move:
1.75%
Sell
23
Novavax (NVAX) is a Sell

Is Novavax a Buy, Sell or Hold?

  • The current Novavax [NVAX] share price is $8.19. The Score for NVAX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVAX Stock Price Chart

What is Novavax's stock price today?

  • The Novavax share price today is $8.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVAX is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

NVAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 44.18 Sell
Chaikin Money Flow: -1249933 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.18 - 9.1) Sell
Bollinger Bands (100): (7.86 - 11.32) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

NVAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.18 Buy
20-day SMA: 8.62 Sell
50-day SMA: 8.73 Sell
200-day SMA: 11.23 Sell
8-day EMA: 8.22 Sell
20-day EMA: 8.48 Sell
50-day EMA: 8.82 Sell
200-day EMA: 9.82 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Novavax Earnings Growth & NVAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.99 per share, and an increase next year of $1.50 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Novavax Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):